INF904
INF904-P2.1
Phase 2 small_molecule active
Quick answer
INF904 for Moderate to Severe Chronic Spontaneous Urticaria (CSU) or Moderate to Severe Hidradenitis Suppurativa (HS) is a Phase 2 program (small_molecule) at InflaRx GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- InflaRx GmbH
- Indication
- Moderate to Severe Chronic Spontaneous Urticaria (CSU) or Moderate to Severe Hidradenitis Suppurativa (HS)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active